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S234 Abstracts / PM R 8 (2016) S151-S332visual deficits as a result of his condition for which he would undergo
rehabilitation.
Setting: Rehabilitation hospital, Outpatient clinic.
Results: The patient was sent to a rehabilitation hospital requiring
moderate to maximum assistance with daily activities and mobility.
He had extensive daily rehabilitation with physical, occupational,
and speech therapy services. The patient’s dramatic recovery and
outpatient follow-up will be further discussed in this report.
Discussion: Bickerstaff’s encephalitis is closely related to Miller
Fisher Syndrome but generally distinguished by encephalopathy and
hyperreflexia. The reason for these differentiating symptoms is the
involvement of the brain stem in the disease process of Bickerstaff’s
encephalitis. Both of these conditions along with pharyngeal-cervi-
cal-brachial-weakness have anti-GQ1b antibodies. There is debate
over whether these are separate conditions or different manifesta-
tions of the same anti-GQ1b syndrome. Plasmapheresis and IVIG
therapy have been found to be effective treatments in these pa-
tients. It is worth analyzing more examples of these conditions,
especially those with a favorable outcome, in order to gain a better
understanding of them.
Conclusions: Bickerstaff’s encephalitis is a rare condition related to
others in the GBS spectrum. It is important to look at potential factors
affecting recovery in less studied disorders such as these in order to
have a greater understanding of their treatment and resulting
prognosis.
Level of Evidence: Level VPoster 226
Unusual Presentation of Eight and a Half Syndrome in
a Patient with Acute Pontine Medullary Stroke: A
Case ReportPhillip Acevedo, MD (TUH, Philadelphia, PA, United States),
Katie Hatt, DO, Ning Cao, MD
Disclosures: Phillip Acevedo: I Have No Relevant Financial Relation-
ships To Disclose
Case/Program Description: This 68-year-old woman with a past
medical history of Type II diabetes mellitus, hypertension, and previ-
ous left cerebrovascular accident with residual right hemiparesis
presented to the ER with nausea and vomiting, hyperglycemia, and
visual disturbances. Examination revealed one and a half syndrome
presenting with right intranuclear ophthalmoplegia (INO) and hori-
zontal gaze palsy. MRI of brain revealed an acute punctate infarct at
the right dorsal pontomedullary junction in addition to chronic lacunar
infarcts. On day 5, she was transferred to an inpatient rehabilitation
facility. However, on rehab day number five, the patient developed
acute right facial droop, incapable of closing her right eye, slurred
speech and otalgia.
Setting: Inpatient Rehabilitation Facility.
Results: Neurology and ENT consults were obtained, MRI was
repeated and progression of the right pontomedullary infarct with
new right facial nerve enhancement was noted. Eight-and-a-Half
Syndrome was diagnosed. A 7-day course of prednisone and vala-
cyclovir with gabapentin for pain control was begun. Occlusion
therapy with OT was initiated for her diplopia. On day 19, patient
was able to be discharged home with resolving slurred speech and
facial palsy.
Discussion: Eight-and-a-half syndrome is caused by a lesion in the
dorsal tegmentum of the caudal pons involving the parapontine
reticular formation or abducens nucleus and MLF, and the nucleus/
fasciculus of the facial nerve. It is a rare presentation of pontine
stroke. Our patient’s delayed presentation of facial palsy made the
diagnosis very challenging.
Conclusions: A rare case of “eight-and-a-half” syndrome is a unique
combination of “one-and-a-half” syndrome plus ipsilateral fascicular
cranial nerve seventh palsy. Thus, the recognition of the syndrome isimportant for appropriate management and to ensure good functional
outcomes.
Level of Evidence: Level VPoster 227
Cauda Equina Syndrome after Lumbar Disk
Herniation: A Case ReportSiena N. Ona, MD (Vidant Rehab Center/East Carolina University/
Brod, Greenville, NC, United States), Raymund V. Millan, MD
Disclosures: Siena Ona: I Have No Relevant Financial Relationships To
Disclose
Case/Program Description: HR is a 36-year-old man with chronic back
pain who was admitted for sudden difficulty in ambulating associated
with nonspecific lower extremity numbness, bowel dysfunction and
urinary retention progressing to inability to void. He had a history of
persistent chronic back pain which was diagnosed as severe sciatica on
prior visits to the ED.
Setting: 75 bed Rehabilitation Hospital.
Results: On day of admission, MRI showed massive extrusion of L3-L4
disk material, segmental stenosis and severe narrowing of compression
of thecal sac. Patient then underwent emergent lumbar decompres-
sion for cauda equina syndrome. Postop patient’s weakness improved
but he was still having weakness on bilateral dorsiflexion, and still had
bowel dysfunction requiring suppositories and bladder dysfunction
requiring in and out cauterization.
Discussion: The presentation of cauda equina syndrome varies from
its classical presentation, especially in its early stages of compression.
In this case for example, the patient’s symptoms were attributed to a
severe case of sciatica. Delayed diagnosis and treatment of this syn-
drome could lead to poor outcomes. National annual incidence of low
back pain is 5%. One quarter of patients with back pain have sciatica.
The most common cause of sciatica is herniation of the lower lumbar
intervertebral disks. In contrast to sciatica, cases of CES after disk
herniation are relatively rare. In one study, the incidence of CES due to
lumbar disk herniation has been reported to range from 1% to 10% of
operated disk cases.
Conclusions: Acute compression of the cauda equina is a neurologi-
cally compromising and debilitating condition. Physicians who eval-
uate low back pain must be able to recognize the signs and symptoms
of this relatively rare but critical spinal syndrome and must expedite
emergent evaluation and intervention.
Level of Evidence: Level VPoster 228
Zolpidem for the Treatment of Neurologic Disorders:
A Systematic ReviewMartin N. Bomalaski, MD (University of Michigan, Ann Arbor, MI,
United States), Mark Peterson, PhD, Edward Claflin, MD
Disclosures: Martin Bomalaski: I Have No Relevant Financial Re-
lationships To Disclose
Objective: To perform a systematic review of all studies using zolpi-
dem to treat neurologic disorders not including insomnia.
Design: Eligibility criteria included any article examining the use of
zolpidem for non-insomnia neurologic disorders on humans, published
and unpublished, written in English, and for all dates up to March 2015.
Searched databases included PubMed, Scopus, Web of Science,
Cochrane Library, and Embase. Positive publication bias was mitigated
by searching ClinicalTrials.gov for unpublished studies. Two rounds of
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Results: Initial combined search results produced 2398 articles. After
exclusion based on title 83 articles remained. An additional 19 articles
were excluded upon review of abstracts, leaving 64 articles for full
manuscript review. There were 29 studies treating movement disor-
ders, subdivided into dystonia (n¼10), Parkinson’s disease (n¼6),
progressive supranuclear palsy (n¼6), spinocerebellar ataxia (n¼2),
catatonia (n¼3), and tardive dyskinesia (n¼1); 24 studies treating
disorders of consciousness, from causes such as traumatic brain injury
(n¼5), anoxic brain injury (n¼6), and other encephalopathies (n¼2);
and 11 studies treating other neurologic conditions including stroke
(n¼4) and dementia (n¼2). Study designs included case reports or
series (n¼35), single subject interventional (n¼14), randomized
controlled trials (n¼6), nonrandomized controlled trials (n¼4), and
cross-over studies (n¼4). Only 14 studies had greater than five sub-
jects. Sedation was observed in eight studies.
Conclusions: Zolpidem has been observed to treat a large variety of
neurologic disorders, most often related to movement disorders and
disorders of consciousness. Much of what is known comes from case
reports and small interventional trials. Additional research with larger
randomized controlled trials is needed to better understand zolpi-
dem’s efficacy in treating these conditions.
Level of Evidence: Level IIIPoster 229
Athlete with Compression of Thenar Motor Branch
and Thumb Digital Branch of Median Nerve: A
Case ReportNaglaa A. Hussein, MD, PhD (Alexandria University, Bronx, NY, United
States), Se Won Lee, MD, Dennis Kim, MD, Arghiris Barbadimos, MD
Disclosures: Naglaa Hussein: I Have No Relevant Financial Relation-
ships To Disclose
Case/Program Description: A 36-year-old right handed analyst man
without significant past medical history, complained of numbness of
left thumb x 1year, intermittent without nocturnal exacerbation.
This was associated with atrophy of his left thumb muscles. He is
still able to hold objects without difficulty. He also has neck pain x
6 months without irradiation to the arms. No muscle weakness or
change in bowel or bladder function. His MRI for left wrist and hand
was normal. He uses kettlebell for muscle strengthening regularly
for several years. He also practicing shooting gun and riding a
mountain bike without gloves for 2 hours once a week for about 10
miles for 3-4 y.
Setting: Outpatient.
Results: Diminished sensation only at tip of left thumb. Atrophy and
weakness of left thenar muscles. Spurling’s, tinel and Phalen tests
were negative bilaterally. Electrodiagnostic studies revealed unob-
tainable sensory nerve action potential l(SNAP) of left median to
thumb only. Intact all SNAP of other upper limb and lower limb
nerves including left median to digit II &III. Motor conduction study
(MCS) of left median nerve to abductor pollicis brevis showed
marked prolonged distal latency. MCS of left median nerve to sec-
ond lumbrical was normal MCS of both ulnar, right median nerve and
left peroneal nerve were normal. All F waves were within normal
limits. Needle EMG for left flexor carpi radialis, first dorsal inter-
osseous, and second lumbrical showed normal study. Left abductor
pollicis brevis showed distant motor units only, without abnormal
rest potential. Ultrasound of left wrist did not reveal any
abnormality.
Discussion: Electrodiagnosis suggested a lesion of left thenar motor
branch as well as a digital sensory branch to thumb. Patient’s athletic
performance could be the reason of compression. No evidence of
carpal tunnel syndrome.
Conclusions: Compression of thenar motor branch and thumb digital
branch of median nerve.
Level of Evidence: Level VPoster 230
Unconventional Dosing of Amantadine in a Patient
with Traumatic Brain Injury: A Case ReportVandana Sood, MD, MS (Baylor College of Medicine, Houston, Texas,
United States), Abana F. Azariah, MD, Katherine O’Brien, PhD,
Joanne Byars, MD, Craig DiTommaso, MD, Sunil Kothari, MD
Disclosures: Vandana Sood: I Have No Relevant Financial Relation-
ships To Disclose
Case/Program Description: A 23-year-old woman sustained severe
traumatic brain injury (TBI) as an unrestrained driver in a high-speed
motor vehicle collision (Glasgow Coma Scale ¼ 3). The patient was
admitted to the Disorders of Consciousness Program in an acute
rehabilitation hospital in a suspected minimally conscious state (MCS),
approximately 2 months post-injury. On physical exam, she was alert,
awake, non-verbal, with spontaneous visual tracking in the left visual
field. There was no evidence of spontaneous communication or
reproducible command following. She was started on amantadine
100mg twice daily to promote functional neurobehavioral recovery.
The patient emerged from a MCS and began to functionally commu-
nicate, however responsiveness was variable, with reduced verbal
output at times. Her Orientation Log (O-Log) score was 8 out of 30. On
two occasions, her amantadine was held due to loss of GI access. Both
times, after stopping amantadine, she demonstrated paradoxical
improvement, demonstrated by her mental status examination scores,
verbalizations, and improved behavior. However, on both occasions,
after a few days off amantadine, her mental status worsened again.
Given this pattern, she was transitioned to an alternate-day dosing
regimen, and ultimately was discharged on amantadine 100 mg every
other day.
Setting: Tertiary care rehabilitation hospital.
Results: On this regimen she continued to improve rapidly as
demonstrated by consistent functional object use, improved verbal
communication and improved participation (O-Log ¼ 21).
Discussion: This case illustrates a novel approach to amantadine
dosing for functional recovery following severe TBI. We suspect that
this alternative dosing regimen led to a more optimal pharmacokinetic
and/or pharmacodynamics profile in this particular patient, possibly
related to individual variability in metabolism, receptor occupancy, or
other factors. The standard dosing regimen produced less cognitive
improvement.
Conclusions: Conventional amantadine dosing twice daily may not be
optimal for all patients with severe TBI. Alternative regimens should
be studied for potentially better functional outcomes.
Level of Evidence: Level VPoster 231
Hemiballismus as the Presenting Symptom of
Polycythemia Vera: A Case ReportEmma Nally, MD (Georgetown University Hospital, Washington,
District of Columbia, United States), Rachna Malhotra, DO
Disclosures: Emma Nally: I Have No Relevant Financial Relationships
To Disclose
Case/Program Description: A previously healthy 74-year-old man
presented to the emergency department with acute onset of isolated
right hemiballismus. Magnetic resonance imaging showed acute infarct
in the left globus pallidus. Laboratory studies revealed hemoglobin of
16.8, hematocrit of 51, platelets of 708, and positive JAK2 V617F
mutation; meeting diagnostic criteria for Polycythemia Vera (PV).
Therapy was initiated with aspirin, statin, and hemodilution with
resolution of slurred speech but persistence of hemiballismus. He was
admitted to acute inpatient rehabilitation as he required an interdis-
ciplinary approach to address his complex physical needs due to
persistent hemiballismus in the absence of sensory or other motor
deficits and medical management of PV.
